• PDA Comments: PDA Input on USP 2020-2025 Revision Cycle

  Nov 4, 2019

• PDA Comments: PDA Responds to EMA Combo Product Reg

  Nov 4, 2019

• PDA Comments: Suggestions for FDA Voluntary Recalls Doc

  Sep 30, 2019

• PDA Comments: Concerns About USP <1235> Revision

  Aug 26, 2019

• PDA Comments: Full Support for WHO WFI Guidance

  Jul 8, 2019

• PDA Comments: Ph. Eur. Tackles Endotoxin Alternative rFC

  May 28, 2019

• PDA Comments: Drug Storage Regulations in Plain Language

  Apr 29, 2019

• Risk-Benefit Analysis More of NCA Scope

  Oct 1, 2018

• PDA Responds to Annex 1 Revision

  Apr 30, 2018

• Changes to USP Council of Experts

  Feb 26, 2018

• Flexibility Needed for PAC

  Jan 2, 2018

• CFDA Encouraged to Review PDA Docs

  Nov 6, 2017

• WHO Should Align with ICH on PACs

  Apr 4, 2017